In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
 

HFA News

Video highlights from Heart Failure Congress

Watch the video interviews from Heart Failure 2017 & World Congress on Acute Heart Failure



01-Take-home-messages-heart-failure-and-iron.jpg

Take home messages: heart failure and iron

02-Take-home-messages-on-cardio-oncology.jpg

Take home messages on cardio-oncology

03-Highlights-from-the-Young-Investigators-Basic-Science.jpg

Highlights from the Young Investigators: Basic Science

04-Take-home-messages-from-the-scientific-programme-chair.jpg

Take home messages from the scientific programme chair

05-Take-home-messages-from-HFA-President.jpg

Take home messages from HFA President

06-Insights-from-Editor-in-Chief-EJHF-Top-tips-to-get-your-papers-accepted.jpg

Insights from Editor in Chief, EJHF: Top tips to get your papers accepted

07-Cardiopoietic-Stem-Cell-Therapy-Improved-Left-Ventricular-Remodeling-CHART-1.jpg

Cardiopoietic Stem Cell Therapy Improved Left Ventricular Remodeling: CHART-1

08-The-HeartLogic-multi-sensor-algorithm-as-a-predictor-of-HF-events-MultiSENSE.jpg

The HeartLogic multi-sensor algorithm as a predictor of HF events: MultiSENSE

09-Heart-Failure-Guidelines---What-has-changed-since-2016.jpg

Heart Failure Guidelines - What has changed since 2016?

 

12-Empagliflozin-decreases-risk-of-kidney-function-decline-in-T2D-EMPA-REG-OUTCOME.jpg

Adherence to guideline recommendations for life saving HF treatment: QUALIFY

10-Adherence-to-guideline-recommendations-for-life-saving-HF-treatment-QUALIFY.jpg

Ivabradine in heart failure with preserved ejection fraction: EDIFY

11-Ivabradine-in-heart-failure-with-preserved-ejection-fraction-EDIFY.jpg

Empagliflozin decreases risk of kidney function decline in T2D: EMPA-REG OUTCOME

13-Heart-failure-with-mid-ejection-fraction-in-CHARM-the-entire-EF-spectrum.jpg

Heart failure with mid ejection fraction in CHARM: the entire EF spectrum

14-The-Grand-Debate-Neprilysin-inhibitor---LCZ-696-(Sacubitril-Valsartan).jpg

The Grand Debate: Neprilysin inhibitor - LCZ 696 (Sacubitril/Valsartan)

15-The-Grand-Debate-Neprilysin-inhibitor---Vasodilators-in-acute-heart-failure.jpg

The Grand Debate: Neprilysin inhibitor - Vasodilators in acute heart failure

16-Heart-Failure-Guidelines-2016---Impact-on-my-practice-one-year-on.jpg

Heart Failure Guidelines 2016 - Impact on my practice one year on

17-RELAX-AHF-2-Serelaxin-in-acute-heart-failure.jpg

RELAX-AHF-2 Serelaxin in acute heart failure

18-Effects-of-Ularitide-on-clinical-course-and-CV-mortality-deep-dive-of-TRUE-AHF.jpg

Effects of Ularitide on clinical course and CV mortality: deep-dive of TRUE-AHF

19-Baseline-BP-and-long-term-outcomes-with-TRV027-an-analysis-of-BLAST-AHF.jpg

Baseline BP and long term outcomes with TRV027: an analysis of BLAST-AHF

20-Bromocriptine-for-the-treatment-of-peripartum-cardiomyopathy.jpg

Bromocriptine for the treatment of peripartum cardiomyopathy

 

 

 

HFA News 2016

HFA News 2016 covered the highlights in the form of short videos focused on 6 main topics, with interviews from major presentations of the congress.
About the ESC
Press and Media
Information
Follow us

         

 Help centre

 Contact us

© 2021 European Society of Cardiology. All rights reserved.